540726 — Trident Texofab Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsSpeculativeMicro CapMomentum Trap

Annual balance sheet for Trident Texofab, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.344	0.388	0.616	1.56	31.6
Net Total Accounts Receivable
Net Total Receivables	304	309	339	367	420
Total Inventory
Total Other Current Assets
Total Current Assets	400	400	467	521	737
Net Property, Plant And Equipment	231	253	233	217	201
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	678	710	773	819	1,006
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	303	302	372	423	407
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	558	580	621	656	533
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	120	130	152	163	472
Total Liabilities & Shareholders' Equity	678	710	773	819	1,006
Total Common Shares Outstanding
Total Preferred Shares Outstanding